The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Dahan Michel since year 2005.
The trader's CIK number is 1669737.
At the time of this reporting, Dahan Michel is the SVP, Chief Business Officer of Akebia Therapeutics, Inc. .
(stock ticker symbol AKBA).
See this page for all insider trading activities at Akebia Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-10-02||AKBA||Akebia Therapeutics, Inc.||Sale||1,398||19.64||27,456|
|2017-09-28||AKBA||Akebia Therapeutics, Inc.||Sale||5,000||19.30||96,500|
|2017-08-15||AKBA||Akebia Therapeutics, Inc.||Sale||5,000||15.00||75,000|
|2017-07-03||AKBA||Akebia Therapeutics, Inc.||Sale||1,399||14.26||19,946|
|2017-04-03||AKBA||Akebia Therapeutics, Inc.||Sale||1,401||9.18||12,858|
|2017-01-01||AKBA||Akebia Therapeutics, Inc.||Sale||1,629||10.49||17,089|
|2016-10-01||AKBA||Akebia Therapeutics, Inc.||Sale||1,401||8.96||12,545|
|2016-07-05||AKBA||Akebia Therapeutics, Inc.||Sale||1,402||7.47||10,468|
|2016-04-04||AKBA||Akebia Therapeutics, Inc.||Sale||1,401||9.41||13,183|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dahan Michel (SVP, Chief Business Officer of Akebia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.